Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 470283, 10 pages
http://dx.doi.org/10.1155/2015/470283
Research Article

The Effect of Primary Cancer Cell Culture Models on the Results of Drug Chemosensitivity Assays: The Application of Perfusion Microbioreactor System as Cell Culture Vessel

1Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Taoyuan 333, Taiwan
2Department of Chemical and Materials Engineering, Chang Gung University, Taoyuan 333, Taiwan
3Graduate Institute of Biochemical and Biomedical Engineering, Chang Gung University, Taoyuan 333, Taiwan
4Department of Otolaryngology-Head and Neck Surgery, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan 333, Taiwan
5Division of Hematology-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan 333, Taiwan

Received 7 August 2014; Revised 17 September 2014; Accepted 19 September 2014

Academic Editor: Jeroen Rouwkema

Copyright © 2015 Chia-Hsun Hsieh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Hatok, E. Babusikova, T. Matakova, D. Mistuna, D. Dobrota, and P. Racay, “In vitro assays for the evaluation of drug resistance in tumor cells,” Clinical and Experimental Medicine, vol. 9, no. 1, pp. 1–7, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. C.-J. Qi, Y.-L. Ning, Y.-L. Zhu, H.-Y. Min, H. Ye, and K.-Q. Qian, “In vitro chemosensitivity in breast cancer using ATP-tumor chemosensitivity assay,” Archives of Pharmacal Research, vol. 32, no. 12, pp. 1737–1742, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. N. P. Bown, M. M. Reid, A. J. Malcolm, E. V. Davison, A. W. Craft, and A. D. J. Pearson, “Cytogenetic abnormalities of small round cell tumours,” Medical and Pediatric Oncology, vol. 23, no. 2, pp. 124–129, 1994. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Sarvi, A. C. Mackinnon, N. Avlonitis et al., “CD133+ cancer stem-like cells in small cell lung cancer are highly tumorigenic and chemoresistant but sensitive to a novel neuropeptide antagonist,” Cancer Research, vol. 74, no. 5, pp. 1554–1565, 2014. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. A. V. Heideman, B. Tholander, B. Grundmark et al., “Chemotherapeutic drug sensitivity of primary cultures of epithelial ovarian cancer cells from patients in relation to tumour characteristics and therapeutic outcome,” Acta Oncologica, vol. 53, no. 2, pp. 242–250, 2014. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. M.-H. Wu and C.-Y. Kuo, “Application of high throughput perfusion micro 3-D cell culture platform for the precise study of cellular responses to extracellular conditions-effect of serum concentrations on the physiology of articular chondrocytes,” Biomedical Microdevices, vol. 13, no. 1, pp. 131–141, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. B. T. Estes, B. O. Diekman, and F. Guilak, “Monolayer cell expansion conditions affect the chondrogenic potential of adipose-derived stem cells,” Biotechnology and Bioengineering, vol. 99, no. 4, pp. 986–995, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. M.-H. Wu, J. P. G. Urban, Z. Cui, and Z. F. Cui, “Development of PDMS microbioreactor with well-defined and homogenous culture environment for chondrocyte 3-D culture,” Biomedical Microdevices, vol. 8, no. 4, pp. 331–340, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. M. H. Wu, Y. H. Chang, Y. T. Liu et al., “Development of high throughput microfluidic cell culture chip for perfusion 3-dimensional cell culture-based chemosensitivity assay,” Sensors and Actuators, B: Chemical, vol. 155, no. 1, pp. 397–407, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. M.-H. Wu, H.-Y. Wang, C.-L. Tai et al., “Development of perfusion-based microbioreactor platform capable of providing tunable dynamic compressive loading to 3-D cell culture construct: demonstration study of the effect of compressive stimulations on articular chondrocyte functions,” Sensors and Actuators B: Chemical, vol. 176, pp. 86–96, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Ning, P. C. Manegold, Y. K. Hong et al., “Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models,” International Journal of Cancer, vol. 128, no. 9, pp. 2038–2049, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. Z.-Q. Ling, C.-J. Qi, X.-X. Lu et al., “Heterogeneity of chemosensitivity in esophageal cancer using ATP-tumor chemosensitivity assay,” Acta Pharmacologica Sinica, vol. 33, no. 3, pp. 401–406, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. A. Forestier, F. Sarrazy, S. Caillat, Y. Vandenbrouck, and S. Sauvaigo, “Functional DNA repair signature of cancer cell lines exposed to a set of cytotoxic anticancer drugs using a multiplexed enzymatic repair assay on biochip,” PLoS ONE, vol. 7, no. 12, Article ID e51754, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. J. El-Ali, P. K. Sorger, and K. F. Jensen, “Cells on chips,” Nature, vol. 442, no. 7101, pp. 403–411, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. S.-B. Huang, S.-S. Wang, C.-H. Hsieh, Y. C. Lin, C.-S. Lai, and M.-H. Wu, “An integrated microfluidic cell culture system for high-throughput perfusion three-dimensional cell culture-based assays: effect of cell culture model on the results of chemosensitivity assays,” Lab on a Chip, vol. 13, no. 6, pp. 1133–1143, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. G. Mehta, A. Y. Hsiao, M. Ingram, G. D. Luker, and S. Takayama, “Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy,” Journal of Controlled Release, vol. 164, no. 2, pp. 192–204, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. L. G. Griffith and M. A. Swartz, “Capturing complex 3D tissue physiology in vitro,” Nature Reviews Molecular Cell Biology, vol. 7, no. 3, pp. 211–224, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. E. Burdett, F. K. Kasper, A. G. Mikos, and J. A. Ludwig, “Engineering tumors: a tissue engineering perspective in cancer biology,” Tissue Engineering B: Reviews, vol. 16, no. 3, pp. 351–359, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. G. Oktem, O. Sercan, U. Guven et al., “Cancer stem cell differentiation: TGFβ1 and versican may trigger molecules for the organization of tumor spheroids,” Oncology Reports, vol. 32, no. 2, pp. 641–649, 2014. View at Publisher · View at Google Scholar · View at PubMed
  20. J. L. Tan, J. Tien, D. M. Pirone, D. S. Gray, K. Bhadriraju, and C. S. Chen, “Cells lying on a bed of microneedles: an approach to isolate mechanical force,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 4, pp. 1484–1489, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. M. S. Kim, J. H. Yeon, and J.-K. Park, “A microfluidic platform for 3-dimensional cell culture and cell-based assays,” Biomedical Microdevices, vol. 9, no. 1, pp. 25–34, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. A. Abbott, “Cell culture: biology's new dimension,” Nature, vol. 424, no. 6951, pp. 870–872, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. D. Loessner, K. S. Stok, M. P. Lutolf, D. W. Hutmacher, J. A. Clements, and S. C. Rizzi, “Bioengineered 3D platform to explore cell-ECM interactions and drug resistance of epithelial ovarian cancer cells,” Biomaterials, vol. 31, no. 32, pp. 8494–8506, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. F. Pampaloni, E. G. Reynaud, and E. H. K. Stelzer, “The third dimension bridges the gap between cell culture and live tissue,” Nature Reviews Molecular Cell Biology, vol. 8, no. 10, pp. 839–845, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. J. L. Lin, M. H. Wu, C. Y. Kuo, K. D. Lee, and Y. L. Shen, “Application of indium tin oxide (ITO)-based microheater chip with uniform thermal distribution for perfusion cell culture outside a cell incubator,” Biomedical Microdevices, vol. 12, no. 3, pp. 389–398, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. A. B. Riemer, H. Kurz, M. Klinger, O. Scheiner, C. C. Zielinski, and E. Jensen-Jarolim, “Vaccination with cetuximab mimotopes and biological properties of induced anti-epidermal growth factor receptor antibodies,” Journal of the National Cancer Institute, vol. 97, no. 22, pp. 1663–1670, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. Y.-C. Tung, A. Y. Hsiao, S. G. Allen, Y.-S. Torisawa, M. Ho, and S. Takayama, “High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array,” Analyst, vol. 136, no. 3, pp. 473–478, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. N. Miyoshi, H. Ishii, K.-I. Nagai et al., “Defined factors induce reprogramming of gastrointestinal cancer cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 1, pp. 40–45, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. M.-H. Wu, J. P. G. Urban, F. C. Zhan, Z. Cui, and X. Xu, “Effect of extracellular pH on matrix synthesis by chondrocytes in 3D agarose gel,” Biotechnology Progress, vol. 23, no. 2, pp. 430–434, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. R. A. Gatenby and R. J. Gillies, “Why do cancers have high aerobic glycolysis?” Nature Reviews Cancer, vol. 4, no. 11, pp. 891–899, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. J.-W. Kim and C. V. Dang, “Cancer's molecular sweet tooth and the warburg effect,” Cancer Research, vol. 66, no. 18, pp. 8927–8930, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. H. Mese, Y. Ueyama, A. Suzuki et al., “Inhibition of telomerase activity as a measure of tumor cell killing by cisplatin in squamous cell carcinoma cell line,” Chemotherapy, vol. 47, no. 2, pp. 136–142, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. M. A. Barry, C. A. Behnke, and A. Eastman, “Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia,” Biochemical Pharmacology, vol. 40, no. 10, pp. 2353–2362, 1990. View at Publisher · View at Google Scholar · View at Scopus